-
Mashup Score: 0Idiopathic Pulmonary Fibrosis: Clinical Pathway - 10 month(s) ago
Idiopathic pulmonary fibrosis (IPF) is an unpredictable and advanced lung disease with fibrotic changes and an overwhelming disease burden to the patient and their caregivers. IPF is associated with high mortality and morbidity, negatively impacting their health-related quality of life (HRQL). Idiopathic pulmonary fibrosis is a progressive lung disorder with scarring of the lungs from an unknown…
Categories: Latest Headlines, NursingTweet
-
Mashup Score: 1Michael Love - 1 year(s) ago
“My heart goes out to anyone in this situation because I’ve been there… And if there’s anything I can do to help you, I’m gonna do it.” Michael Love worked over twenty years as a pipe fitter. He’s also a “foodie,” serving his signature corned beef for friends by request. He considers himself a “softie” and a “people person” always prioritizing care for others in need. A life-long “car fanatic,”…
Source: www.henryford.comCategories: General Medicine News, Latest HeadlinesTweet-
Michael Love can be described in many ways: a foodie, people person, car fanatic - & the recipient of 2 donor lungs, 2 separate times. After being diagnosed with #IdiopathicPulmonaryFibrosis & 2 years to live, his life changed drastically. Read his story: https://t.co/biv9D1Ptji https://t.co/L8RXirqFjx
-
-
Mashup Score: 0Rare Impact Awards - NORD's Rare Impact Awards - 1 year(s) ago
This very special event will celebrate NORD’s legacy and achievements, and honor those individuals and organizations doing remarkable work on behalf of the rare disease community.
Source: NORD's Rare Impact AwardsCategories: Latest Headlines, Rare DiseaseTweet-
Introducing NORD #RareImpactAwards honoree, Bernie Williams! Williams is known in the #RareDisease community as a voice, advocate, and champion for patients and families impacted by #IdiopathicPulmonaryFibrosis. Secure your ticket to the Awards today: https://t.co/gdSDtcXO9d https://t.co/mb38tBx4Vi
-
-
Mashup Score: 3
Insilico Medicine has been granted the FDA’s first Orphan Drug Designation for a drug discovered and designed using artificial intelligence (AI)—the company’s lead pipeline candidate INS018_055, a small molecule inhibitor treatment for idiopathic pulmonary fibrosis (IPF).
Categories: Future of Medicine, Latest HeadlinesTweet-
.@InSilicoMeds has been granted the FDA’s first Orphan Drug Designation for a drug discovered and designed using #artificialintelligence (#AI) for #idiopathicpulmonaryfibrosis. Learn more: https://t.co/zinrsmt7z5 #drugdiscovery https://t.co/ZiJuvk6gxE
-
-
Mashup Score: 4
Insilico Medicine has been granted the FDA’s first Orphan Drug Designation for a drug discovered and designed using artificial intelligence (AI)—the company’s lead pipeline candidate INS018_055, a small molecule inhibitor treatment for idiopathic pulmonary fibrosis (IPF).
Categories: Future of Medicine, Latest HeadlinesTweet-
.@InSilicoMeds has been granted the FDA’s first Orphan Drug Designation for a drug discovered and designed using #artificialintelligence (#AI) for #idiopathicpulmonaryfibrosis. Learn more: https://t.co/zinrsmt7z5 #drugdiscovery https://t.co/CENei8BOdv
-
-
Mashup Score: 7
Insilico Medicine has been granted the FDA’s first Orphan Drug Designation for a drug discovered and designed using artificial intelligence (AI)—the company’s lead pipeline candidate INS018_055, a small molecule inhibitor treatment for idiopathic pulmonary fibrosis (IPF).
Categories: Future of Medicine, Latest HeadlinesTweet-
.@InSilicoMeds has been granted the FDA’s first Orphan Drug Designation for a drug discovered and designed using #artificialintelligence (#AI) for #idiopathicpulmonaryfibrosis. Learn more: https://t.co/zinrsmt7z5 #drugdiscovery https://t.co/FYRFEaWMHq
-
-
Mashup Score: 0
Current antifibrotic agents are not curative for idiopathic pulmonary fibrosis (IPF). Moreover, existing preclinical models do not fully replicate the human …
Source: YouTubeCategories: Latest Headlines, PulmonologyTweet-
This #RedinMotion video explores the chorioallantoic membrane of chick embryos as a potential model for #IdiopathicPulmonaryFibrosis. Find out more about how this model can aid the development of novel #therapies here: https://t.co/qkm1rPL9co
-
-
Mashup Score: 0
Current antifibrotic agents are not curative for idiopathic pulmonary fibrosis (IPF). Moreover, existing preclinical models do not fully replicate the human …
Source: YouTubeCategories: Latest Headlines, PulmonologyTweet-
This #RedinMotion video explores the chorioallantoic membrane of chick embryos as a potential model for #IdiopathicPulmonaryFibrosis. Find out more about how this model can aid the development of novel #therapies here: https://t.co/qkm1rPL9co
-
-
Mashup Score: 0
Current antifibrotic agents are not curative for idiopathic pulmonary fibrosis (IPF). Moreover, existing preclinical models do not fully replicate the human …
Source: YouTubeCategories: Latest Headlines, PulmonologyTweet-
This #RedinMotion video explores the chorioallantoic membrane of chick embryos as a potential model for #IdiopathicPulmonaryFibrosis. Find out more about how this model can aid the development of novel #therapies here: https://t.co/qkm1rPL9co
-
-
Mashup Score: 0
Current antifibrotic agents are not curative for idiopathic pulmonary fibrosis (IPF). Moreover, existing preclinical models do not fully replicate the human …
Source: YouTubeCategories: Latest Headlines, PulmonologyTweet-
This #RedinMotion video explores the chorioallantoic membrane of chick embryos as a potential model for #IdiopathicPulmonaryFibrosis. Find out more about how this model can aid the development of novel #therapies here: https://t.co/qkm1rPL9co
-
Friendly reminder to complete FREE CE during the month of June! This activity discusses the clinical pathway to treat #IdiopathicPulmonaryFibrosis and offers 1.2 CH of CE credit. Complete by June 30: https://t.co/peyEUt6A4s. #NPsLead https://t.co/45yNGiQXAM